The Research and Development team at Constellation Pharmaceuticals focuses on discovering and developing innovative small molecule treatments that target epigenetic mechanisms in tumor and immune cells. Comprising experts across scientific and clinical disciplines, the team collaborates to advance drug candidates from early-stage discovery through clinical development, leveraging cutting-edge computational biology, translational research, and biomarker strategies to benefit patients with cancer.
View all